Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification

Background: Curcumin (CUR) displays the capability of suppressing the proliferation and metastasis of various cancer cells. However, the effects and underline mechanisms of CUR to treat triple-negative breast cancer (TNBC) have not been systematically elucidated with an appropriate method. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zhicheng, Chen, Guanghui, Shi, Yonghui, Lin, Ying, Ou, Jiebin, Zhu, Hua, Wu, Junyan, Li, Guocheng, Lv, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393234/
https://www.ncbi.nlm.nih.gov/pubmed/36003508
http://dx.doi.org/10.3389/fphar.2022.920514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393234/
https://www.ncbi.nlm.nih.gov/pubmed/36003508
http://dx.doi.org/10.3389/fphar.2022.920514

Ejemplares similares